[go: up one dir, main page]

WO2009096817A3 - Agent for reducing the degree of acute alcoholic intoxication (inebriation) and the use thereof - Google Patents

Agent for reducing the degree of acute alcoholic intoxication (inebriation) and the use thereof Download PDF

Info

Publication number
WO2009096817A3
WO2009096817A3 PCT/RU2009/000033 RU2009000033W WO2009096817A3 WO 2009096817 A3 WO2009096817 A3 WO 2009096817A3 RU 2009000033 W RU2009000033 W RU 2009000033W WO 2009096817 A3 WO2009096817 A3 WO 2009096817A3
Authority
WO
WIPO (PCT)
Prior art keywords
agent
inebriation
degree
reducing
alcoholic intoxication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2009/000033
Other languages
French (fr)
Russian (ru)
Other versions
WO2009096817A2 (en
Inventor
Андрей Александрович Иващенко
Николай Филиппович САВЧУК
Александр Васильевич Иващенко
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alla Chem LLC
Original Assignee
Alla Chem LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alla Chem LLC filed Critical Alla Chem LLC
Publication of WO2009096817A2 publication Critical patent/WO2009096817A2/en
Publication of WO2009096817A3 publication Critical patent/WO2009096817A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a novel agent which reduces the degree of acute alcoholic intoxication (inebriation) and exhibits anti-alcohol withdrawal action, to a biologically active additive, pharmaceutical composition and a medicinal agent which decrease alcohol withdrawal syndrome caused by the overconsumption of ethyl alcohol-containing products.
PCT/RU2009/000033 2008-01-31 2009-01-29 Agent for reducing the degree of acute alcoholic intoxication (inebriation) and the use thereof Ceased WO2009096817A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2008103155/04A RU2358723C1 (en) 2008-01-31 2008-01-31 Antiwithdrawal agent, biologically active additive, pharmaceutical composition, medical product and method of producing
RU2008103155 2008-01-31

Publications (2)

Publication Number Publication Date
WO2009096817A2 WO2009096817A2 (en) 2009-08-06
WO2009096817A3 true WO2009096817A3 (en) 2009-09-24

Family

ID=40913450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2009/000033 Ceased WO2009096817A2 (en) 2008-01-31 2009-01-29 Agent for reducing the degree of acute alcoholic intoxication (inebriation) and the use thereof

Country Status (2)

Country Link
RU (1) RU2358723C1 (en)
WO (1) WO2009096817A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2404976C1 (en) * 2009-05-29 2010-11-27 Андрей Александрович Иващенко Agent to reduce alcohol addiction, pharmaceutical composition, method for making thereof, medicinal agent and method of treating
RU2418580C1 (en) * 2009-12-29 2011-05-20 Михаил Григорьевич Воронков Zinc-containing ethanol poisoning antidote and method of treatment with its application
RU2557960C1 (en) * 2014-07-01 2015-07-27 Аллан Герович Бениашвили Orally disintegrating tablet of dehydroepiandrosterone and/or combination of dehydroepiandrosterone and l-theanine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004165A1 (en) * 1987-10-19 1989-05-18 Haklitch Joseph A Detoxifying food supplement
US5585467A (en) * 1990-12-04 1996-12-17 Il-Yang Pharmaceutical Co., Ltd. Proteoglycan(G009) effective in enhancing antitumor immunity
RU2160589C1 (en) * 2000-05-18 2000-12-20 Алекс Кашлинский Agent for reducing alcoholic drunkenness, preventing and eliminating alcohol intoxication and hangover syndrome and method for reducing alcoholic drunkenness, preventing and eliminating alcohol intoxication and hangover syndrome using this agent
CA2453159A1 (en) * 2001-07-10 2003-01-23 Penam Investments Pty Ltd A composition and uses therefor for combating hangover
US20070213400A1 (en) * 2004-05-06 2007-09-13 Taiyokagaku Co., Ltd. Alcohol-metabolism enhancing composition and ingesta containing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121428A1 (en) * 1999-12-24 2004-06-24 Masakazu Sugimoto Process for producing l-amino acid and novel gene
RU2250778C1 (en) * 2004-02-26 2005-04-27 Мясников Дмитрий Николаевич Means for reducing unfavorable consequences of acute alcohol intoxication

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004165A1 (en) * 1987-10-19 1989-05-18 Haklitch Joseph A Detoxifying food supplement
US5585467A (en) * 1990-12-04 1996-12-17 Il-Yang Pharmaceutical Co., Ltd. Proteoglycan(G009) effective in enhancing antitumor immunity
RU2160589C1 (en) * 2000-05-18 2000-12-20 Алекс Кашлинский Agent for reducing alcoholic drunkenness, preventing and eliminating alcohol intoxication and hangover syndrome and method for reducing alcoholic drunkenness, preventing and eliminating alcohol intoxication and hangover syndrome using this agent
CA2453159A1 (en) * 2001-07-10 2003-01-23 Penam Investments Pty Ltd A composition and uses therefor for combating hangover
US20070213400A1 (en) * 2004-05-06 2007-09-13 Taiyokagaku Co., Ltd. Alcohol-metabolism enhancing composition and ingesta containing the same

Also Published As

Publication number Publication date
WO2009096817A2 (en) 2009-08-06
RU2358723C1 (en) 2009-06-20

Similar Documents

Publication Publication Date Title
WO2013078371A3 (en) Methods and compositions for reducing alcohol toxicity
WO2009147075A3 (en) Pharmaceutical compositions containing a crystalline form of posaconazole
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2010031720A3 (en) Novel antibody formulation
WO2011039768A3 (en) Pharmaceutical compositions for reducing alcohol-induced dose dumping
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2007084314A3 (en) MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2009089494A3 (en) Pharmaceutical compositions
WO2010021607A3 (en) Pharmaceutical formulation
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
BR112012011328A2 (en) akt inhibitors
WO2009004629A3 (en) A method for decreasing symptoms of alcohol consumption
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2010055082A3 (en) New crystal form of sunitinib malate
WO2009135593A3 (en) Solid pharmaceutical formulation with delayed release
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2010055119A3 (en) Pharmaceutical composition comprising pimobendan
WO2010049449A3 (en) Novel salts of sunitinib
CL2007002862A1 (en) USE OF THE EPIDERMIC GROWTH FACTOR (EGF) TO TREAT SENSITIVE-MOTOR, PAINFUL NEUROPATHY AND MANIFESTATIONS OF ISCHEMICAL NEURITIS; PHARMACEUTICAL COMPOSITION INCLUDED BY EGF; AND USE OF THE COMPOSITION BEFORE SUCH.
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2008137134A3 (en) Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
WO2007132314A3 (en) Substituted piperidino phenyloxazolidinones
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09706073

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09706073

Country of ref document: EP

Kind code of ref document: A2